Tuberculosis
Tuberculosis is an irresistible illness that by and large has an impact the lungs. It is the second most noteworthy executioner because of a solitary irresistible operator all through the world, and in 2012, 1.3 million individuals lapse from the malady, with 8.6 million becoming sick. The tuberculosis bacterium causes TB. It is the degree through the air from individual to individual, when individuals with TB influencing the lungs hack, sniffle, saliva, snicker or talk. TB is irresistible, however it is difficult to get. The odds of getting TB from somebody stay alive or work with are a lot higher than from an outsider. The manifestations incorporate Coughing, chills, tiredness, Fever, Loss of Weight, and Loss of hunger.
- Active TB Disease
- Miliary TB
- Latent TB Infection
- Clinical Trials
Related Conference of Tuberculosis
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
Tuberculosis Conference Speakers
Recommended Sessions
- Pulmonary Rehabilitation
- Advances in Respiratory Medicine
- Asthma and Allergy
- Cardiopulmonary Sciences
- Chronic Obstructive Pulmonary Disease
- Lung Cancer Screening, Diagnosis & Treatment
- Lung Transplantation
- Pediatric Pulmonology & Critical care
- Pulmonary Hypertension
- Respiratory and Pulmonary Therapies
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome (SARS)
- Tuberculosis
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
